Abbott Laboratories - 36 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of April 18, 2019 is 73.92.
- The all-time high Abbott Laboratories stock price is 80.06, which is 8.3% above the current share price.
- The Abbott Laboratories 52-week high stock price is 80.06, which is 8.3% above the current share price.
- The Abbott Laboratories 52-week low stock price is 57.09, which is 22.8% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 68.34.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 75.0105 | 69.1758 | 80.0600 | 65.9111 | 73.9200 | 2.68% |
| 2018 | 63.4985 | 57.4736 | 73.9235 | 55.2713 | 71.9926 | 29.04% |
| 2017 | 47.0879 | 37.3157 | 56.1831 | 37.3157 | 55.7921 | 52.00% |
| 2016 | 38.3145 | 40.0140 | 43.0058 | 34.0902 | 36.7042 | -12.32% |
| 2015 | 42.7892 | 40.9734 | 47.4440 | 36.1946 | 41.8595 | 1.89% |
| 2014 | 37.0686 | 34.1231 | 42.3148 | 32.1788 | 41.0829 | 20.08% |
| 2013 | 31.6249 | 28.1518 | 34.5516 | 28.1518 | 34.2124 | 23.75% |
| 2012 | 26.3385 | 23.5714 | 30.4438 | 22.5969 | 27.6455 | 18.31% |
| 2011 | 21.0762 | 19.5236 | 23.4093 | 18.5194 | 23.3677 | 19.46% |
| 2010 | 20.5743 | 21.8843 | 22.6780 | 18.5671 | 19.5603 | -9.84% |
| 2009 | 19.3376 | 21.1859 | 22.7237 | 16.5514 | 21.6954 | 2.77% |
| 2008 | 21.7051 | 21.8042 | 23.6975 | 19.5602 | 21.1108 | -3.77% |
| 2007 | 21.1646 | 18.9154 | 23.0832 | 18.9154 | 21.9371 | 16.59% |
| 2006 | 17.3088 | 15.0820 | 19.0544 | 15.0820 | 18.8150 | 25.13% |
| 2005 | 17.2177 | 17.5973 | 18.9512 | 14.3498 | 15.0362 | -14.52% |
| 2004 | 15.5513 | 16.3030 | 17.7180 | 13.7564 | 17.5898 | 8.24% |
| 2003 | 14.3352 | 13.8192 | 16.4425 | 11.8945 | 16.2507 | 17.74% |
| 2002 | 15.7530 | 19.0838 | 19.7527 | 10.6686 | 13.8020 | -27.56% |
| 2001 | 17.0614 | 16.3230 | 19.4016 | 14.2930 | 19.0530 | 15.98% |
| 2000 | 14.1041 | 11.7753 | 18.9073 | 9.9910 | 16.4281 | 34.48% |
| 1999 | 14.6346 | 16.2926 | 17.7433 | 11.2067 | 12.2160 | -25.40% |
| 1998 | 13.6429 | 11.2153 | 16.6268 | 11.0905 | 16.3762 | 50.34% |
| 1997 | 10.2323 | 8.3356 | 11.4132 | 8.3356 | 10.8926 | 29.72% |
| 1996 | 7.4813 | 6.8748 | 9.3896 | 6.3879 | 8.3968 | 22.49% |
| 1995 | 6.3251 | 5.3460 | 7.3403 | 5.1268 | 6.8551 | 28.23% |
| 1994 | 4.8506 | 4.7047 | 5.5098 | 4.2621 | 5.3460 | 10.76% |
| 1993 | 4.3627 | 4.9207 | 4.9207 | 3.7414 | 4.8268 | -1.91% |
| 1992 | 4.9635 | 5.4285 | 5.4987 | 4.3631 | 4.9207 | -11.49% |
| 1991 | 4.1999 | 3.4834 | 5.5592 | 3.2034 | 5.5592 | 53.39% |
| 1990 | 3.0685 | 2.7838 | 3.6646 | 2.5333 | 3.6243 | 32.59% |
| 1989 | 2.3740 | 1.9169 | 2.8191 | 1.8726 | 2.7335 | 41.47% |
| 1988 | 1.8792 | 1.9496 | 2.0853 | 1.7250 | 1.9322 | -0.11% |
| 1987 | 2.3046 | 1.9030 | 2.6800 | 1.7239 | 1.9343 | 5.82% |
| 1986 | 1.7572 | 1.3610 | 2.1771 | 1.2762 | 1.8280 | 33.58% |
| 1985 | 1.0909 | 0.8126 | 1.4037 | 0.8002 | 1.3685 | 63.89% |
| 1984 | 0.8586 | 0.9193 | 0.9598 | 0.7600 | 0.8350 | -7.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $129.838B | $30.578B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $112.952B | 16.51 |
| Stryker (SYK) | United States | $67.256B | 24.66 |
| Boston Scientific (BSX) | United States | $48.820B | 23.72 |
| Baxter (BAX) | United States | $37.991B | 24.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.550B | 15.71 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.615B | 0.00 |
| Canopy Growth (CGC) | Canada | $14.912B | 0.00 |
| ResMed (RMD) | United States | $14.218B | 26.96 |
| Aurora Cannabis (ACB) | Canada | $9.118B | 64.29 |
| Bio-Rad Laboratories (BIO) | United States | $8.765B | 50.28 |
| Perrigo (PRGO) | Ireland | $6.633B | 10.75 |
| Hill-Rom Holdings (HRC) | United States | $6.374B | 19.72 |
| Insulet (PODD) | United States | $4.900B | 1642.60 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.701B | 0.00 |
| ICU Medical (ICUI) | United States | $4.568B | 28.29 |
| Haemonetics (HAE) | United States | $4.189B | 37.16 |
| Hutchison China MediTech (HCM) | China | $4.046B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.268B | 0.00 |
| Neogen (NEOG) | United States | $2.958B | 48.10 |
| NuVasive (NUVA) | United States | $2.784B | 24.18 |
| Quidel (QDEL) | United States | $2.365B | 21.17 |
| National Vision Holdings (EYE) | United States | $2.220B | 43.66 |
| Aphria (APHA) | $1.917B | 0.00 | |
| HEXO (HEXO) | $1.424B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.349B | 19.38 |
| VAREX IMAGING (VREX) | United States | $1.222B | 23.93 |
| Cardiovascular Systems (CSII) | United States | $1.190B | 854.00 |
| AtriCure (ATRC) | United States | $1.049B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.931B | 25.16 |
| Omeros (OMER) | United States | $0.908B | 0.00 |
| PetIQ (PETQ) | United States | $0.862B | 24.67 |
| MacroGenics (MGNX) | United States | $0.791B | 0.00 |
| Cerus (CERS) | United States | $0.787B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.737B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.689B | 0.00 |
| Evolus (EOLS) | United States | $0.681B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.666B | 22.66 |
| OraSure Technologies (OSUR) | United States | $0.594B | 25.86 |
| Surmodics (SRDX) | United States | $0.546B | 79.43 |
| LeMaitre Vascular (LMAT) | United States | $0.536B | 25.46 |
| Meridian Bioscience (VIVO) | United States | $0.531B | 15.82 |
| Quanterix (QTRX) | United States | $0.492B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.322B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.321B | 20.88 |
| Insys Therapeutics (INSY) | United States | $0.313B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.305B | 125.85 |
| Vapotherm (VAPO) | United States | $0.296B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.271B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.213B | 2.91 |
| Zynex (ZYXI) | United States | $0.171B | 18.31 |
| Chimerix (CMRX) | United States | $0.133B | 0.00 |
| Bovie Medical (APYX) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.125B | 6.68 |
| Chembio Diagnostics (CEMI) | United States | $0.121B | 0.00 |
| Surface Oncology (SURF) | United States | $0.113B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.090B | 0.00 |
| Female Health (VERU) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.06 |
| CAS Medical Systems (CASM) | United States | $0.072B | 0.00 |
| Neurotrope (NTRP) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.071B | 21.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Senestech (SNES) | United States | $0.034B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.031B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.018B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 13.71 |
